Department of ICU, The Cancer Hospital of Harbin Medical University, Harbin, China.
Department of Anesthesia, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Ann Med. 2021 Dec;53(1):653-661. doi: 10.1080/07853890.2021.1925149.
Acute respiratory distress syndrome (ARDS) is characterized by severe local and systemic inflammation. Ac2-26, an Annexin A1 Peptide, can reduce the lung injury induced by reperfusion via the inhibition of inflammation. The present study aims to evaluate the effect and mechanism of Ac2-26 in ARDS.
Thirty-two rats were anaesthetized and randomized into four groups: sham (S), ARDS (A), ARDS/Ac2-26 (AA), and ARDS/Ac2-26/BOC-2 (AAB) groups. Rats in the S group received saline for intratracheal instillation, while rats in the other three groups received endotoxin for intratracheal instillation, in order to prepare the ARDS and inject the saline, Ac2-26, and Ac2-26 combined with BOC-2. After 24 h, the PaO/FiO ratio was calculated. The lung tissue wet-to-dry weight ratio and the protein level in bronchoalveolar lavage fluid (BALF) were tested. Then, the cytokines in BALF and serum, and the inflammatory cells in BALF were investigated. Afterwards, the oxidative stress response and histological injury was evaluated. Subsequently, the epithelium was cultured and analyzed to estimate the effect of Ac2-26 on apoptosis.
Compared to the S group, all indexes worsened in the A, AA, and AAB groups. Furthermore, compared to the S group, Ac2-26 significantly improved the lung injury and alveolar-capillary permeability, and inhibited the oxidative stress response. In addition, Ac2-26 reduced the local and systemic inflammation through the regulation of pro- and anti-inflammatory cytokines, and the decrease in inflammatory cells in BALF. Moreover, Ac2-26 inhibited the epithelium apoptosis induced by LPS through the modulation of apoptosis-regulated proteins. The protective effect of Ac2-26 on ARDS was partially reversed by the FPR inhibitor, BOC-2.
Ac2-26 reduced the lung injury induced by LPS, promoted alveolar-capillary permeability, ameliorated the local and systemic inflammation, and inhibited the oxidative stress response and apoptosis. The protection of Ac2-26 on ARDS was mainly dependent on the FPR pathway.
急性呼吸窘迫综合征(ARDS)的特征是严重的局部和全身炎症。Ac2-26 是一种 Annexin A1 肽,通过抑制炎症可以减少再灌注引起的肺损伤。本研究旨在评估 Ac2-26 在 ARDS 中的作用和机制。
32 只大鼠麻醉后随机分为四组:假手术组(S)、ARDS 组(A)、ARDS/Ac2-26 组(AA)和 ARDS/Ac2-26/BOC-2 组(AAB)。S 组大鼠给予气管内生理盐水滴注,其他三组大鼠给予气管内内毒素滴注,以制备 ARDS 模型,并注射生理盐水、Ac2-26 和 Ac2-26 与 BOC-2 的混合物。24 小时后,计算 PaO/FiO 比值。检测肺组织湿重/干重比和支气管肺泡灌洗液(BALF)中的蛋白水平。然后,检测 BALF 和血清中的细胞因子以及 BALF 中的炎症细胞。随后,评估氧化应激反应和组织学损伤。随后,培养上皮细胞并分析 Ac2-26 对细胞凋亡的影响。
与 S 组相比,A、AA 和 AAB 组的所有指标均恶化。此外,与 S 组相比,Ac2-26 显著改善了肺损伤和肺泡毛细血管通透性,并抑制了氧化应激反应。此外,Ac2-26 通过调节促炎和抗炎细胞因子以及降低 BALF 中的炎症细胞来减轻局部和全身炎症。此外,Ac2-26 通过调节凋亡调节蛋白抑制 LPS 诱导的上皮细胞凋亡。FPR 抑制剂 BOC-2 部分逆转了 Ac2-26 对 ARDS 的保护作用。
Ac2-26 减轻 LPS 引起的肺损伤,促进肺泡毛细血管通透性,改善局部和全身炎症,抑制氧化应激反应和细胞凋亡。Ac2-26 对 ARDS 的保护主要依赖于 FPR 途径。